Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2015 1
2016 2
2017 2
2018 1
2020 2
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies.
García-Calderón CB, Sierro-Martínez B, García-Guerrero E, Sanoja-Flores L, Muñoz-García R, Ruiz-Maldonado V, Jimenez-Leon MR, Delgado-Serrano J, Molinos-Quintana Á, Guijarro-Albaladejo B, Carrasco-Brocal I, Lucena JM, García-Lozano JR, Blázquez-Goñi C, Reguera-Ortega JL, González-Escribano MF, Reinoso-Segura M, Briones J, Pérez-Simón JA, Caballero-Velázquez T. García-Calderón CB, et al. Among authors: garcia guerrero e. Front Immunol. 2023 Apr 14;14:1152498. doi: 10.3389/fimmu.2023.1152498. eCollection 2023. Front Immunol. 2023. PMID: 37122702 Free PMC article.
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells.
García-Guerrero E, Rodríguez-Lobato LG, Sierro-Martínez B, Danhof S, Bates S, Frenz S, Haertle L, Götz R, Sauer M, Rasche L, Kortüm KM, Pérez-Simón JA, Einsele H, Hudecek M, Prommersberger SR. García-Guerrero E, et al. Haematologica. 2023 Feb 1;108(2):568-580. doi: 10.3324/haematol.2022.281339. Haematologica. 2023. PMID: 36722406 Free PMC article.
Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib.
Rodríguez-Gil A, Escamilla-Gómez V, Nufer M, Andújar-Sánchez F, Lopes-Ramos T, Bejarano-García JA, García-Guerrero E, Calderón-Cabrera C, Caballero-Velázquez T, García-Calderón CB, Hernández-Díaz P, Reguera-Ortega JL, Rodríguez-Torres N, Martínez-Cibrián N, Rodríguez-Barbosa JI, Villadiego J, Pérez-Simón JA. Rodríguez-Gil A, et al. Among authors: garcia guerrero e. Sci Rep. 2022 May 19;12(1):8348. doi: 10.1038/s41598-022-12407-x. Sci Rep. 2022. PMID: 35589917 Free PMC article.
Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease.
Ramos TL, García-Guerrero E, Caballero-Velázquez T, Rodríguez-Gil A, Caracuel-García R, Nufer M, Robles-Frías MJ, Barbado MV, Pérez-Simón JA. Ramos TL, et al. Among authors: garcia guerrero e. Bone Marrow Transplant. 2021 Dec;56(12):3049-3058. doi: 10.1038/s41409-021-01452-1. Epub 2021 Sep 23. Bone Marrow Transplant. 2021. PMID: 34556806 Free PMC article.
Uptake and delivery of antigens by mesenchymal stromal cells.
Sánchez-Abarca LI, Alvarez-Laderas I, Díez Campelo M, Caballero-Velázquez T, Herrero C, Muntión S, Calderón C, García-Guerrero E, Sánchez-Guijo F, Del Cañizo C, San Miguel J, Pérez-Simón JA. Sánchez-Abarca LI, et al. Among authors: garcia guerrero e. Cytotherapy. 2013 Jun;15(6):673-8. doi: 10.1016/j.jcyt.2013.01.216. Epub 2013 Mar 21. Cytotherapy. 2013. PMID: 23522868
Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab.
García-Guerrero E, Götz R, Doose S, Sauer M, Rodríguez-Gil A, Nerreter T, Kortüm KM, Pérez-Simón JA, Einsele H, Hudecek M, Danhof S. García-Guerrero E, et al. Leukemia. 2022 Jan;36(1):297. doi: 10.1038/s41375-021-01355-6. Leukemia. 2022. PMID: 34845317 Free PMC article. No abstract available.
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo.
Barbado MV, Medrano M, Caballero-Velázquez T, Álvarez-Laderas I, Sánchez-Abarca LI, García-Guerrero E, Martín-Sánchez J, Rosado IV, Piruat JI, Gonzalez-Naranjo P, Campillo NE, Páez JA, Pérez-Simón JA. Barbado MV, et al. Among authors: garcia guerrero e. Int J Cancer. 2017 Feb 1;140(3):674-685. doi: 10.1002/ijc.30483. Epub 2016 Nov 10. Int J Cancer. 2017. PMID: 27778331 Free article.
14 results